| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |